[ET Net News Agency, 30 September 2021] Sihuan Pharmaceutical Holdings Group Ltd.
(00460) said PLLA gel (product name: Karlian) (2ml/unit), which is independently
researched, developed and manufactured by the group, has formally obtained the medical
device manufacturing licence approved by the National Medical Products Administration
(NMPA).
Karlian can be used as skin barrier on skin surface or wound, and accelerate the
reproducing of collagen and tissue cells on wound. (RC)